Benzonatate
- Product NDC
- 42708-171
- 11-digit product format
- 427080171
- Labeler code
- 42708
- Product ID
- 42708-171_459bb6d9-8893-ed4f-e063-6294a90a028f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- QPharma Inc
- Application
- ANDA206948
- Marketing category
- ANDA
- Marketing start
- 2018-12-21
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Benzonatate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BENZONATATE | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5P4DHS6ENR |
| Rxcui | 283417 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42708-171-21 | Benzonatate | 21 in 1 BOTTLE, PLASTIC | CAPSULE | 21 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42708-171 | BENZONATATE CAPSULE [QPHARMA INC] | 2 | Current NDC, 1 package rows | 20241123_fbd07fb0-c49c-a838-e053-6394a90a5f0e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 42708-171-21 | 42708017121 | 21 CAPSULE in 1 BOTTLE, PLASTIC (42708-171-21) | 21 capsule | 2023-05-19 | Yes | No | Current |